Evidence map›Paper›PMID 41327310›Full record

ReviewJournal of nanobiotechnology2025

Functions and applications of enzymes in nucleic acid nanotechnology.

Qinze Rong, Zibin Chu, Ye Xu, Liang Ma, Lei Wang, Shihui Wang, Zhe Yin, Xin Su

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Qinze Rong *State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Zibin Chu *State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Ye Xu *State Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Liang MaClinical Laboratory , China-Japan Friendship Hospital, Beijing, 100029, China.
Lei WangState Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Shihui WangState Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China.
Zhe YinState Key Laboratory of Pathogen and Biosecurity , Academy of Military Medical Sciences , Beijing, 100071, China. jerry9yin@163.com.
Xin SuState Key Laboratory of Organic-Inorganic Composites, Beijing Key Laboratory of Bioprocess, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, China. xinsu@mail.buct.edu.cn.

Funding

Fundamental Research Funds for the Central Universities PT2406National Natural Science Foundation of China 32271521 and 31971361State Key Research Development Program of China 2022YFC2603900
6 · The paper itself

Abstract

Nucleic acid nanotechnology (NAN) has emerged as a powerful platform for constructing programmable molecular architectures, with broad applications spanning biomedicine, materials science, and molecular computing. While numerous reviews have covered the design principles and functional modalities of enzyme-free NAN systems, a comprehensive framework for understanding enzyme-involved NAN remains conspicuously absent. Given the growing interest in enzyme-involved systems, enzymes offer distinct advantages to NAN, including enhanced programmability, dynamic control, and expanded functional versatility. This review addresses that gap by systematically categorizing the enzymatic toolkit-including polymerases, modifying enzymes, endo-/exonucleases, ligases, other protein-based enzymes, as well as nucleic acid enzymes such as DNAzymes, ribozymes, and XNAzymes-and elucidating their roles in enabling structural assembly and dynamic control at the molecular level. Enzymes function not only as assembly agents for nucleic acid nanostructures, facilitating strand extension, ligation, cleavage, and chemical modification, but also as essential driver tools mediating degradation, release, and template-guided polymerization. Their integration has led to highly adaptive and reconfigurable systems with capabilities far surpassing enzyme-free counterparts. We further highlight key advances in enzyme-powered NAN across diverse frontiers, including in vitro diagnostics (IVD), cellular and in vivo imaging, DNA data storage and computing, biomimetic material synthesis, and drug delivery. By mapping catalytic mechanisms to functional outputs, and identifying current bottlenecks in specificity, modularity, and integration, this review establishes a unified conceptual foundation and design roadmap for the next generation of enzyme-driven nucleic acid nanodevices.

Indexed as

EnzymesNanotechnologyNucleic AcidsAnimalsDNADNA, CatalyticHumansNanostructuresDNADNA, CatalyticEnzymesNucleic AcidsDNA nanostructureEnzymeNucleic acid nanotechnologyNucleic acid reaction network

Identifiers

PMID41327310
PMCPMC12670827

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.